NEW YORK (GenomeWeb News) – German genetic engineering company Gene Bridges said today that it has licensed its DNA recombination technology to Japanese pharmaceutical firm Daiichi Sankyo.

The company said that the technology, which is patented in Japan as a "Novel DNA Cloning Method," is used to generate targeting vectors or for modifying E. coli chromosomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.